// App-Quantinova.ai

: NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001

Researchers

Presenter

  • Deborah Bruner

Principal Investigators

  • David Grosshans

  • Andre Konski

  • Andre Robidoux

  • Vijayananda Kundapur

  • Kiran Devisetty

  • Sunjay Shah

  • Kenneth Usuki

  • Bethany Anderson

  • Baldassarre Stea

  • Harold Yoon

  • Jing Li

  • Nadia Laack

  • Tim Kruser

  • Steven Chmura

  • Wenyin Shi

  • Minesh P Mehta

  • Lisa Kachnic

Medical Centers

  • Emory University, Winship Cancer Institute, Atlanta, GA

  • East Bay Radiation Oncology Center/Eden Medical Center, Castro Valley, CA, USA

  • Penn Medicine-Chester County Hospital, West Chester, PA, USA

  • Hotel-Dieu de Montreal, CHUM, Montreal, QC, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Wayne State University Karmanos Cancer Institute, Detroit, MI

  • Delaware/Christiana Care NCI Community Oncology Research Program, Newark, DE, USA

  • University of Rochester, Rochester, NY

  • University of Wisconsin Hosp and Clinics, Madison, WI

  • University of Arizona Medical Center-University Campus, Tucson, AZ, USA

  • Heartland Cancer Research NCORP, Decatur, IL

  • University of Chicago Comprehensive Cancer Center, Chicago, IL

  • Miami Cancer Institute, Miami, FL

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Des-gamma-carboxyprothrombin

Drug/Treatment

  • Memantine

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved